Cross-Site Scripting Vulnerability in Inrove Software BiEticaret
CVE-2026-5793
6.1MEDIUM
Key Information:
- Status
- Vendor
- CVE Published:
- 9 July 2026
What is CVE-2026-5793?
A cross-site scripting vulnerability exists in Inrove Software's BiEticaret, which improperly neutralizes input during web page generation. This flaw allows attackers to execute malicious scripts in the context of a user's browser session, potentially leading to credential theft and session hijacking. The vulnerability impacts versions of BiEticaret prior to v3.3.57. Users are advised to upgrade to the latest version to mitigate this risk.
Affected Version(s)
BiEticaret 0
